The combination of angiotensin receptor-neprilysin inhibitor and sodium-glucose cotransporter-2 inhibitors in heart failure with reduced ejection fraction patients comorbid with diabetes mellitus

被引:0
|
作者
Hsiao, F. C. [1 ]
Lin, C. P. [1 ]
Chang, P. C. [1 ]
Wang, C. L. [1 ]
Chu, P. H. [1 ]
机构
[1] Linkou Chang Gung Mem Hosp, Taoyuan, Taiwan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1049 / 1049
页数:1
相关论文
共 50 条
  • [2] Effectiveness and safety of angiotensin receptor-neprilysin inhibitor and sodium-glucose cotransporter-2 inhibitors for patients with heart failure with reduced ejection fraction: a meta-analysis
    Huang, Yun
    Fang, Chongbo
    Zhang, YuYu
    Ma, Lili
    Zhou, Hua
    Ye, Honghua
    [J]. JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 (02) : 123 - 131
  • [3] Combining sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors in heart failure patients with reduced ejection fraction and diabetes mellitus: A multi-institutional study
    Hsiao, Fu-Chih
    Lin, Chia-Pin
    Tung, Ying-Chang
    Chang, Po-Cheng
    McMurray, John J., V
    Chu, Pao-Hsien
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 330 : 91 - 97
  • [4] Comparing angiotensin receptor-neprilysin inhibitors with sodium-glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus
    Tsai, Ming-Lung
    Lin, Yuan
    Lin, Ming-Shyan
    Tsai, Tzu-Hsien
    Yang, Ning-, I
    Wang, Chao-Yung
    Hsieh, I-Chang
    Hung, Ming-Jui
    Chen, Tien-Hsing
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [5] Sodium-glucose cotransporter-2 inhibitors for heart failure with reduced ejection fraction
    Falk, Jamie
    Potter, Jennifer
    Turgeon, Ricky D.
    [J]. CANADIAN FAMILY PHYSICIAN, 2021, 67 (09) : 678 - 678
  • [6] Association Between Use of Sodium-Glucose Cotransporter-2 Inhibitors or Angiotensin Receptor-Neprilysin Inhibitor and the Risk of Atherosclerotic Cardiovascular Disease With Coexisting Diabetes and Heart Failure
    Lin, Ya-Wen
    Lin, Chun-Hsiang
    Lin, Cheng-Li
    Lin, Che-Huei
    Lin, Ming-Hung
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2024, 29
  • [7] Preventing heart failure admissions with sodium-glucose cotransporter-2 inhibitors versus angiotensin receptor-neprilysin inhibitors: A target trial emulation study
    Jeong, Han Eol
    Park, Sohee
    Bea, Sungho
    Noh, Yunha
    Lip, Gregory Y. H.
    You, Seng Chan
    Choi, Eue-Keun
    Shin, Ju-Young
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 311 - 311
  • [8] In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction
    Rao, Vishal N.
    Murray, Evan
    Butler, Javed
    Cooper, Lauren B.
    Cox, Zachary L.
    Fiuzat, Mona
    Green, Jennifer B.
    Lindenfeld, JoAnn
    McGuire, Darren K.
    Nassif, Michael E.
    Brien, Cara
    Pagidipati, Neha
    Sharma, Kavita
    Vaduganathan, Muthiah
    Vardeny, Orly
    Fonarow, Gregg C.
    Mentz, Robert J.
    Greene, Stephen J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (20) : 2004 - 2012
  • [9] Effects of sodium-glucose cotransporter-2 inhibitors on nutritional status in heart failure with reduced ejection fraction
    Arslan, Kadem
    Yilmaz, Emre
    Aydin, Ercan
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2022, 68 (11): : 1576 - 1581
  • [10] Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure With Preserved Ejection Fraction and Type 2 Diabetes
    Fu, Edouard L.
    Patorno, Elisabetta
    Everett, Brendan
    Vaduganathan, Muthiah
    Solomon, Scott
    Levin, Raisa
    Schneeweiss, Sebastian
    Desai, Rishi
    [J]. CIRCULATION, 2022, 146